Insmed Inc (INSM)
60.50 x 5 88.06 x 1
Post-market by (Cboe BZX)
72.65 +2.45 (+3.49%) 04/17/25 [NASDAQ]
60.50 x 5 88.06 x 1
Post-market 71.50 -1.15 (-1.58%) 19:14 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | INSM | GMAB | BMRN | ||
| Company | Insmed Inc | Genmab A/S ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 69.86 | 19.47 | 58.44 | ||
| High | 72.67 | 20.16 | 59.62 | ||
| Low | 69.86 | 19.42 | 58.00 | ||
| Last | 72.65 | 20.04 | 59.17 | ||
| Change | +2.45 | +0.49 | +0.35 | ||
| % Change | +3.49% | +2.51% | +0.60% | ||
| Volume | 1,501,000 | 1,135,300 | 1,247,100 | ||
| 20-Day Average Volume | 2,230,365 | 1,599,410 | 2,032,985 | ||
| Previous Close | 70.20 | 19.55 | 58.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 72.66 | 19.14 | 64.53 | ||
| 20-Day Raw Stochastic | 58.06% | 89.46% | 30.81% | ||
| 20-Day Relative Strength | 48.57% | 50.89% | 38.78% | ||
| Weighted Alpha | +29.97 | -30.31 | -34.33 | ||
| Today's Opinion | 40% Sell | 88% Sell | 72% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 72% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.10% since 04/10/25 | +11.27% since 04/10/25 | +5.06% since 04/10/25 | ||
| Low | 64.35 on 04/11/25 | 18.44 on 04/11/25 | 55.08 on 04/11/25 | ||
| High | 72.67 on 04/17/25 | 20.16 on 04/17/25 | 60.93 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -6.58% since 03/17/25 | -3.65% since 03/17/25 | -17.30% since 03/17/25 | ||
| Low | 60.40 on 04/09/25 | 17.24 on 04/09/25 | 52.93 on 04/09/25 | ||
| High | 81.50 on 03/24/25 | 20.59 on 03/18/25 | 73.18 on 03/27/25 | ||
| 3-Month | |||||
| %Chg | +0.19% since 01/17/25 | -3.65% since 01/17/25 | -3.84% since 01/17/25 | ||
| Low | 60.40 on 04/09/25 | 17.24 on 04/09/25 | 52.93 on 04/09/25 | ||
| High | 84.91 on 02/21/25 | 24.33 on 03/07/25 | 73.51 on 03/07/25 | ||
| 6-Month | |||||
| %Chg | -2.18% since 10/17/24 | -12.72% since 10/17/24 | -14.83% since 10/17/24 | ||
| Low | 60.40 on 04/09/25 | 17.24 on 04/09/25 | 52.93 on 04/09/25 | ||
| High | 84.91 on 02/21/25 | 24.33 on 03/07/25 | 73.51 on 03/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,209,224 | 13,261,831 | 11,289,872 | ||
| Shares Outstanding, K | 181,820 | 661,768 | 190,804 | ||
| Annual Sales | 363,710,000 | 3,121,270,000 | 2,853,920,000 | ||
| Annual Net Income | -913,770,000 | 1,137,380,000 | 426,860,000 | ||
| Last Quarter Sales | 104,440,000 | 921,940,000 | 747,310,000 | ||
| Last Quarter Net Income | -235,550,000 | 554,680,000 | 124,940,000 | ||
| 60-Month Beta | 1.07 | 1.07 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 02/20/25 | 0.57 on 02/12/25 | 0.92 on 02/19/25 | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.77 | 21.63 | ||